Eric Shaff | President and CEO |
Terri Young | EVP, Chief Commercial and Strategy Officer |
Lisa von Moltke | EVP and Chief Medical Officer |
David Arkowitz | EVP, CFO and Head of Business Development |
David Ege | EVP, Chief Technology Officer |
Matthew Henn | EVP, Chief Scientific Officer |
Carlo Tanzi | IR Officer |
Mark Breidenbach | Oppenheimer |
Joseph Thome | Cowen |
Tessa Romero | JPMorgan |
John Newman | Canaccord Genuity |
Stephen Sloan | Goldman Sachs |
Keay Nakae | Chardan Capital Markets |
Hello. My name is Chris, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Q1 2023 Seres Therapeutics Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.